Company Search:
Advanced Search
Sponsored Links
Hengkang Medical Group Co Ltd Company Snapshot
Hengkang Medical Group Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hengkang Medical Group Co Ltd with three other companies in this sector in CHINA : Zhuzhou Qianjin Pharmaceutical Co., Ltd. (2019 sales of 3.52 billion Chinese Renmimbi [US$502.16 million] of which 49% was Medicine Retail Sales & Wholesales), Zhejiang Xianju Pharmaceutical Co Limited (3.71 billion Chinese Renmimbi [US$528.36 million] of which 85% was Domestic), and Guangxi Wuzhou Zhongheng Group, Ltd. (3.81 billion Chinese Renmimbi [US$543.32 million] of which 89% was Pharmaceutical Segment).

Sales Analysis. Hengkang Medical Group Co Ltd reported sales of 3.68 billion Chinese Renmimbi (US$524.85 million) for the year ending December of 2019. This represents a decrease of 4.0% versus 2018, when the company's sales were 3.84 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 98.5% decline in Investment, from 48.47 million Chinese Renmimbi to 724,752.68 Chinese Renmimbi. There were also decreases in sales in Medical Service (down 1.0% to 3.20 billion Chinese Renmimbi) and Chinese Herbal Medicine and Chinese Herbal (down 74.1% to 42.55 million Chinese Renmimbi) and Other (down 21.0% to 27.94 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Medicine and Daily Chemical (up 11.9% to 429.07 million Chinese Renmimbi) and Healthcare Products (up 6.8% to 3.54 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hengkang Medical Group Co Ltd
  Stock Performance Chart for Hengkang Medical Group Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 1.74
(Figures in Chinese Renmimbi)
1 Week 4.2%   13 Weeks 42.6%  
4 Weeks -22.0%   52 Weeks -43.0%  
Hengkang Medical Group Co Ltd Key Data:
  Ticker: 002219 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,683,928,179
(Year Ending Jan 2020).
Employees: 7,818
  Currency: Chinese Renmimbi Market Cap: 3,245,511,388
  Fiscal Yr Ends: December Shares Outstanding: 1,865,236,430
  Share Type: Gu Closely Held Shares: 1,110,967,030
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.